Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topics that matter most, balances emerging trends with scientific evidence, and reflects the growing importance of longevity within modern healthcare.

They explore the difference between healthy ageing—grounded in well-established principles such as sleep, nutrition, exercise, stress management and social connection—and the consumer longevity movement, where interventions are often expensive, and the supporting evidence is still evolving.

The conversation examines the gap between health insights and meaningful behaviour change, asking why biomarker data alone rarely translates into better health outcomes. They also discuss whether healthcare systems and insurers are likely to invest more in preventative healthcare beyond wearables and lifestyle programmes.

Other topics include the importance of social health and loneliness, the evidence gap in women’s health, why strength should take priority over the pursuit of being “small”, the opportunities and limitations of GLP-1 medicines, longevity’s communication challenge, and how artificial intelligence could reshape primary care and expand access to preventative healthcare. HLTH and Longevity: Healthy Ageing, Evidence and Women’s Health

Beyond Longevity examines how longevity has moved from a niche topic into mainstream healthcare, using HLTH’s major US and Europe conferences as a bellwether. Host Daphna speaks with HLTH head of content, Jody Tropeano Greene and HLTH US content lead, Alexa Mikhail, about how they build agenda programming that surfaces trending issues while insisting on credible evidence, and why they are dedicating a full day to longevity.

They distinguish healthy ageing (population-level, researched basics such as sleep, nutrition, movement, stress and relationships) from consumer longevity biohacking (often expensive and sometimes unproven), discuss the “insight–action gap” from biomarker data, and debate whether insurers will fund prevention beyond wearables and lifestyle supports.

HLTH USA is the premier event taking place November 15-18 in Las Vegas, where leaders from across the healthcare ecosystem come together to share insights, spark inspiration, and shape the global health agenda. Attendees gain a comprehensive view of healthcare advancements, from policy and market dynamics to cutting-edge consumer health technologies - all aimed at improving the well-being of individuals worldwide.

Register and save $1,000+ by Friday, July 31

https://hlth.com/

Jody Tropeano Greene

Head of Content, HLTH

https://www.linkedin.com/in/jodytropeano/

Alexa Mikhail

Content Lead, HLTH US

Senior health and longevity writer, SHE Media, Flow Space

https://www.linkedin.com/in/alexamikhail/

00:00 Welcome to Beyond Longevity

00:25 Why HLTH Matters

01:26 Meet Jody and Alexa

03:02 How HLTH Picks Topics

04:41 Healthy Ageing vs Longevity

07:51 Credibility Over Hype

09:05 When Trends Go Mainstream

11:49 Prevention and Insurance

15:58 Loneliness as Longevity

17:05 What Makes Startups Break Through

19:19 Women Left Out of Data

23:44 Strength Over Smallness

26:41 Practical Healthspan Habits

27:45 Elevating Women's Health

29:19 Building Consumer Wellness

31:24 Longevity Goes Mainstream

32:21 Making Basics Profitable

34:17 Longevity Language Problem

35:24 Preparedness And Community

38:45 GLP1 Promise And Risks

42:13 Healthcare In Ten Years

45:17 Assumptions To Challenge

47:22 Rapid Fire And Wrap

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Longevity medicine has created a strange new kind of patient: the healthy person convinced something must be wrong.A wearable flags poor recovery. One test says your body is ageing faster than it shou...

20 Syys 1h

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

At 16, Chris Mirabile was lying in a hospital bed the night before brain surgery, wondering whether he would wake up the next morning. Years later, as he was building NOVOS, he lost his mother to panc...

13 Syys 1h 14min

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Recorded at HLTH Europe in Amsterdam, Part Two of our special series looks at four very different ways technology could help healthcare move earlier, become more personalised and make better use of th...

6 Syys 57min

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

What happens when technology stops simply tracking our health and starts helping us understand what to do about it?Recorded at HLTH Europe in Amsterdam, this episode of Beyond Longevity features three...

30 Elo 42min

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease?In this episode of Beyond Longevity, Daphna...

23 Elo 56min

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Elo 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Elo 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Elo 48min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
tiedekulma-podcast
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
hippokrateen-vastaanotolla
rss-bios-podcast
docemilia
rss-politiikasta-podcast
rss-tiedetta-vai-tarinaa
rss-ranskaa-raakana
rss-lihavuudesta-podcast
radio-antro
rss-radplus